Excessive uterine bleeding in adolescents with diabetes mellitus
Keywords:
MENSTRUATION DISTURBANCES, UTERINE HEMORRHAGE, ADOLESCENT, DIABETES MELLITUS, CONTRACEPTION.Abstract
Introduction: menstrual cycle alterations are frequent in adolescents with diabetes, being oligomenorrhea and amenorrhea the most observed, while excessive uterine bleeding is not frequent in these patients. Excessive uterine bleeding may be due to multiple causes, with biological and social repercussions that represent a concern for family members and professionals.
Objective: to update the subject of blood alterations that may be the cause and/or appear as a consequence of excessive uterine bleeding, as well as the treatment in adolescents with diabetes mellitus.
Methods: an updated national and international bibliographic review was carried out to prepare a document that includes the hematological alterations that may be associated in adolescents with diabetes and excessive uterine bleeding, as well as the integral management. The review was structured by sections according to what was obtained as part of the research carried out.
Development: excessive uterine bleeding in patients with diabetes can be caused by various hematological disorders, particularly hemorrhagic diathesis, with anemia being its main consequence, which implies that the diagnostic evaluation should take into account both diseases when facing this problem. The therapeutic conduct, although it does not differ from that indicated for non-diabetic patients, always requires some particular considerations.
Conclusions: excessive uterine bleeding is less frequent in diabetic adolescents than in non-diabetic adolescents and its main hematological consequence is anemia. Treatment does not differ from that of non-diabetics, except for the need for adequate metabolic control of the underlying disease.
Downloads
References
1. Moon L, Pérez G, Stambough K, Dietrich J. Menstrual disorders and blood dyscrasias in adolescents. En: Sanfilippo’s. Textbook of pediatric and adolescent gynecology.2.ªedición; 2020. p. 165-70.
2. Sepúlveda-Agudelo J, Sepúlveda-Sanguino AJ. Sangrado uterino anormal y PALM COEIN. Ginecol Obstet Mex[Internet]. 2020[citado 15/04/2021]; 88(1): 59-67. Disponible en: https://doi.org/10.24245/gom.v88i1.3467
3. Marnach ML, Laughlin SK. Evaluation and Management of Abnormal Uterine Bleeding. Mayo Clin Proc[Internet]. 2019[citado 15/04/2021]; 94(2): 326-335. Disponible en: https://doi.org/10.1016/j.mayocp.2018.12.012 .
4. Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee: The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 143 (3):393–408. Disponible en: https://doi.org/10.1002/ijgo.12666
5. International Diabetes Federation. IDF diabetes atlas:. IDF Atlas 10th edition Accessed August 1, [Internet]. 2021[citado 15/04/2021]. Disponible en: http://www.diabetesatlas.org
6. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019. La Habana: Dirección Nacional de Estadísticas[Internet]; 2020[citado 15/04/2021]. Disponible en: Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%c3%b3nico-Espa%c3%b1ol-2019-ed-2020.pdf
7. Rughani A, Friedman JE, Tryggestad JB. Type 2 Diabetes in Youth: the Role of Early Life Exposures. Curr Diab Rep[Internet] 2020[citado 15/04/2021]; 20(9):45. Disponible en: https://doi.org/10.1007/s11892-020-01328-6 .
8. González-Ricardo Y, Hernández-Yero A, Domínguez-Alonso E, Maceo-Coello T. Irregularidades menstruales y de hormonas sexuales en mujeres que se les diagnosticó la diabetes tipo 1 antes de la menarquia o después de esta. Rev Cubana Endocrinol [Internet] 2010[citado 15/04/2021]; 21(1): 51-61. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-575505
9. Thong EP, Codner E, Laven JSE, Teede H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol[Internet] 2020[citado 15/04/2021]; 8(2):134-149. Disponible en: https://doi.org/10.1016/S2213-8587(19)30345-6
10. Sekulovski N, Whorton AE, Shi M, Hayashi K, MacLean JA. Periovulatory insulin signaling is essential for ovulation, granulosa cell differentiation, and female fertility. FASEB J[Internet] 2020[citado 15/04/2021]; 34: 2376-91. Disponible en: https://doi.org/10.1096/fj.201901791R .
11. Souza MA, Freitas RWJF, Lima LS, Santos MA, Zanetti ML, Damasceno MMC. Health-related quality of life of adolescents with type 1 diabetes mellitus. Rev. Latino-Am. Enfermagem[Internet] 2019[citado 15/04/2021]; 27: e3210. Disponible en: http://dx.doi.org/10.1590/1518-8345.2961.3210
12. Holesh JE, Bass AN, Lord M. Physiology, Ovulation. 2021 May 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [Internet] 2022 Jan [citado 15/04/2021]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK441996/
13. Aguirre N., Pereira J., Barriga F., Wietstruck MA., Panes O, Sepúlveda P, et al . Trastornos hereditarios de la coagulación en adolescentes con sangrado menstrual excesivo, ¿debemos evaluar la vía fibrinolítica?. Rev. chil. pediatr[Internet] 2020[citado 15/04/2021]; 91(3): 385-390. Disponible en: https://dx.doi.org/10.32641/rchped.v91i3.1571.
14. Vaidya AR, Wolska N, Vara D, Mailer RK, Schröder K, Pula G. Diabetes and Thrombosis: A Central Role for Vascular Oxidative Stress. Antioxidants (Basel) [Internet] 2021 Apr 29 [citado 15/04/2021]; 10(5): 706. Disponible en: https://dx.doi.org/10.3390/antiox10050706
15. Wang Y, Yang P, Yan Z, Liu Z, Ma Q, Zhang Z, Wang Y, Su Y. The Relationship between Erythrocytes and Diabetes Mellitus. J Diabetes Res[Internet] 2020 Feb 25 [citado 15/04/2021]; 2021: 6656062. Disponible en: https://doi.org/10.1155/2021/6656062
16. Guo W, Zhou Q, Jia Y, Xu J. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review. Med Sci Monit[Internet] 2019[citado 15/04/2021]; 25: 8371-8378. Disponible en: https://dx.doi.org/10.12659/MSM.916719 .
17. Sahay M, Kalra S, Badani R, Bantwal G, Bhoraskar A, Das AK, Et al. Diabetes and Anemia: International Diabetes Federation (IDF) - Southeast Asian Region (SEAR) position statement. Diabetes Metab Syndr[Internet] 2017[citado 15/04/2021]; 11(Suppl 2): S685-S695. Disponible en: https://doi.org/10.1016/j.dsx.2017.04.026
18. Asmaa A, Solimar MD, Safinaz A. Elhabashy MD, Rasha A, Thabet MD, Nouran Y, Salah El Din, MBBCh. Iron Deficiency Anemia in Children and Adolescents with Type I Diabetes, Is it a Real Problem?. The Medical Journal of Cairo University[Internet] 2021[citado 15/04/2021]; 89: 1603-1619. Disponible en: https://doi.org/10.21608/mjcu.2021.194977
19. Guo W, Zhou Q, Jia Y, Xu J. Increased Levels of Glycated Hemoglobin A1c and Iron Deficiency Anemia: A Review. Med Sci Monit[Internet] 2019 Nov 7 [citado 15/04/2021]; 25: 8371-8378. Disponible en: https://dx.doi.org/10.12659/MSM.916719
20. Nicolaides NC, Matheou A, Vlachou F, Neocleous V, Skordis N. Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management. Acta Biomed[Internet] 2020[citado 15/04/2021]; 91(3): e2020085. Disponible en: https://dx.doi.org/10.23750/abm.v91i3.10162
21. Relke N, Chornenki NLJ, Sholzberg M. Tranexamic acid evidence and controversies: An illustrated review. Res Pract Thromb Haemost[Internet] 2021[citado 15/04/2021]; 14;5(5):e12546. Disponible en: https://doi.org/10.1002/rth2.12546 .
22. Rahman S, Khan FS, Samin KA, Afridi N, Ahmed M. Efficacy of Oral Tranexamic Acid Versus Combined Oral Contraceptives for Heavy Menstrual Bleeding. Cureus[Internet] 2021 Oct 29[citado 15/04/2021]; 13(10): e19122. Disponible en: https://doi.org/10.7759/cureus.19122
23. Lethaby A, Wise MR, Weterings MA, Bofill Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev[Internet] 2019[citado 15/04/2021]; 2019(2): CD000154. Disponible en: https://doi.org/10.1002/14651858.CD000154.pub3 .
24. Bofill M, Lethaby A, Fergusson RJ. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev[Internet] 2019 Aug[citado 15/04/2021]; 8(8): CD000329. Disponible en: https://doi.org/10.1002/14651858.CD000329.pub3
25. Beelen P, van den Brink MJ, Herman MC, Geomini PMAJ, Dekker JH, Duijnhoven RG, et al. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. Am J Obstet Gynecol[Internet] 2021[citado 15/04/2021]; 224(2): 187.e1-187.e10. Disponible en: https://doi.org/10.1016/j.ajog.2020.08.016
26. Lopez LM, Grimes DA, Schulz KF. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev[Internet] 2019 Nov 12 [citado 15/04/2021]; 2019(11). Disponible en: https://doi.org/10.1002/14651858.CD006133.pub5 .
27. Bofill M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev[Internet] 2020 Jun 12 [citado 15/04/2021]; 6(6):CD002126. Disponible en: https://doi.org/10.1002/14651858.CD002126.pub4
28. Deligeoroglou E, Karountzos V. Abnormal Uterine Bleeding including coagulopathies and other menstrual disorders. Best Pract Res Clin Obstet Gynaecol[Internet] 2018[citado 15/04/2021]; 48:51-61. Disponible en: https://doi.org/10.1016/j.bpobgyn.2017.08.016
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
